Guilherme Carneiro Barreto

ORCID: 0000-0002-3127-0500
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • T-cell and Retrovirus Studies
  • Viral-associated cancers and disorders
  • Cancer-related gene regulation
  • Oral health in cancer treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Neutropenia and Cancer Infections
  • Cystic Fibrosis Research Advances

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2025

Instituto do Câncer do Estado de São Paulo
2025

Universidade de São Paulo
2021-2022

Bronchoscopy is frequently performed in the management of patients with acute leukemia due to their high susceptibility infections. In this setting, it context lung infiltrates on imaging and persistent fever immunocompromised subjects. This study aimed evaluate utility bronchoscopy leukemia, its diagnostic yield, impact decisions. a single-center cross-sectional that included diagnosed any phenotype who received intensive chemotherapy. Consecutive underwent as part work-up for associated...

10.1016/j.htct.2025.103741 article EN cc-by Hematology Transfusion and Cell Therapy 2025-01-01

Nodal peripheral T-cell lymphomas [nPTCL] constitute a heterogeneous group of rare malignancies with aggressive biological behavior and poor prognosis. Epigenetic phenomena involving genes that control DNA-methylation histone deacetylation play central role in their pathogenesis. However, the mutational landscape epigenetic regulators has never been reported Latin American patients prognostic impact remains controversial.From 2000 to 2019, 59-Brazilian nPTCL were eligible for screening...

10.3233/cbm-220013 article EN Cancer Biomarkers 2022-09-06

Abstract Nodal mature T-cell lymphomas (nMTCL) comprises a heterogeneous group of rare malignancies with aggressive biological behavior and poor prognosis. Epigenetic phenomena, including mutations in genes that control DNA methylation histone deacetylation, addition to inactivating the RhoA GTPase, play central role its pathogenesis constitute potential new targets for therapeutic intervention. Tumor mutational burden (TMB) reflects process clonal evolution, predicts response anti-cancer...

10.1186/s13148-022-01395-4 article EN cc-by Clinical Epigenetics 2022-12-01
Coming Soon ...